Chemoprevention by pravastatin, a 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor, of N-methyl-N-nitrosourea-induced colon carcinogenesis in F344 rats.
about
HMG-CoA reductase inhibitor mevastatin enhances the growth inhibitory effect of butyrate in the colorectal carcinoma cell line Caco-2Statin use and association with colorectal cancer survival and risk: case control study with prescription data linkage.Simvastatin induces derepression of PTEN expression via NFkappaB to inhibit breast cancer cell growth.Exploiting the critical perioperative period to improve long-term cancer outcomesMultitargeted low-dose GLAD combination chemoprevention: a novel and promising approach to combat colon carcinogenesis.MYC phosphorylation, activation, and tumorigenic potential in hepatocellular carcinoma are regulated by HMG-CoA reductaseRelationship between the use of statins and patient survival in colorectal cancer: a systematic review and meta-analysis.Statins and cancer prevention.Statin use and cancer risk: an epidemiologic review.Molecular markers and targets for colorectal cancer prevention.Chronic statin therapy and the risk of colorectal cancer.Marketed drugs used for the management of hypercholesterolemia as anticancer armament.Statin use and risk of colorectal cancer in a cohort of middle-aged men in the US: a prospective cohort study.Mevalonate promotes the growth of tumors derived from human cancer cells in vivo and stimulates proliferation in vitro with enhanced cyclin-dependent kinase-2 activity.Obesity is associated with an increased prevalence of advanced adenomatous colon polyps in a male veteran population.Statins in esophageal cancer cell lines: promising lead?Statin use does not prevent recurrent adenomatous polyp formation in a VA population.Melatonin potentiates the anti-tumour effect of pravastatin in rat mammary gland carcinoma model.
P2860
Q28201997-5AE1A126-B0A9-481E-942C-87C4CE59400DQ30574356-8EFADE30-BFAD-4A2F-9502-4901AA7386C9Q33678607-3DDF3F2F-4A00-4FDA-9847-DB04A1004F26Q33871661-62A97D60-65F3-4B0C-AC59-4078553D228DQ34342182-0208D630-9F95-4A9C-8062-DD4A640E3589Q34687185-D9FB69CA-E082-4E2A-A5EC-FB34CA73E707Q35648346-F8555888-B574-40F6-B55E-E36175339D7FQ36337970-7E2E41AD-A31E-46C4-AB13-B6D7932EC764Q36508082-403D2C65-4D17-42CB-9687-230981EF9D8FQ37045028-27471B9A-166F-4931-81D5-5E0F47249B65Q38456987-F3165E35-043F-4BB6-B2EB-82842CF72775Q41080847-12366569-5257-497E-9280-FE201B7BCC8EQ44652129-528DE088-0986-4303-BDCB-1FCC763AB6E2Q44904792-100171DF-22C2-4532-9D2A-F9D10E9376F2Q45331514-1AE4DEBD-2FC7-4FBC-ADCC-32972F4C0D27Q46678846-3893E94A-FD3C-4483-8B69-EF8D753F0B20Q49113359-1A01F5D0-E9EF-4A02-B4C1-195AEF4A5450Q51405325-95AEBEF4-D88B-4BFE-A110-E0E2A602C79E
P2860
Chemoprevention by pravastatin, a 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor, of N-methyl-N-nitrosourea-induced colon carcinogenesis in F344 rats.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Chemoprevention by pravastatin ...... n carcinogenesis in F344 rats.
@en
Chemoprevention by pravastatin ...... n carcinogenesis in F344 rats.
@nl
type
label
Chemoprevention by pravastatin ...... n carcinogenesis in F344 rats.
@en
Chemoprevention by pravastatin ...... n carcinogenesis in F344 rats.
@nl
prefLabel
Chemoprevention by pravastatin ...... n carcinogenesis in F344 rats.
@en
Chemoprevention by pravastatin ...... n carcinogenesis in F344 rats.
@nl
P2093
P2860
P1476
Chemoprevention by pravastatin ...... n carcinogenesis in F344 rats.
@en
P2093
P2860
P304
P356
10.1111/J.1349-7006.1996.TB02103.X
P577
1996-08-01T00:00:00Z